News
Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...
A blood test can accurately predict whether someone without a known risk of preeclampsia is likely to develop the potentially ...
Genomic Testing Cooperative Receives UKCA Mark for its Portfolio of Hematology, Solid Tumors and Liquid Biopsy Profiles covering DNA and RNA ...
Scientists have transformed RNA, a biological molecule present in all living cells, into a biosensor that can detect tiny ...
Research by Rutgers University-New Brunswick scientists centers on RNA, a nucleic acid that plays a crucial role in most ...
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
AIR-001 is designed to restore functional alpha-1 antitrypsin (M-AAT) protein production by precisely repairing the SERPINA1 mutation (PiZ) to address the underlying cause of both lung and liver ...
AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...
Budget cuts, delays to grant reviews, and layoffs of federal workers at agencies like the NIH and the National Science Foundation have affected nearly every research organization in the US. If ...
Unlike other hemophilia therapies, Qfitlia is indicated for both hemophilia A and B, and can be given in patients regardless ...
Large-scale data on the hepatitis D virus (HDV)/hepatitis B virus (HBV) co-infection rate is needed to estimate the current ...
Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results